首页 文献索引 SCI期刊 AI助手
期刊目录筛选

期刊名:Scandinavian journal of urology

缩写:SCAND J UROL

ISSN:2168-1805

e-ISSN:2168-1813

IF/分区:2.8/Q2

文章目录 更多期刊信息

共收录本刊相关文章索引1011
Clinical Trial Case Reports Meta-Analysis RCT Review Systematic Review
Classical Article Case Reports Clinical Study Clinical Trial Clinical Trial Protocol Comment Comparative Study Editorial Guideline Letter Meta-Analysis Multicenter Study Observational Study Randomized Controlled Trial Review Systematic Review
Helena Hallencreutz Grape,Magnus Grabe,Philip Von Rosen et al. Helena Hallencreutz Grape et al.
Chronic primary prostate pain syndrome (PPPS), usually referred to as chronic prostatitis with chronic pelvic pain syndrome (CP/CPPS), affects approximately 10% of all men. The National Institute of Health-Chronic Prostatitis Symptom Index ...
Maria Utter,Fredrik Altmark,Marcin Popiolek et al. Maria Utter et al.
Objective: The aim of this study was to evaluate the utilization and impact of emergency computed tomography (CT) on the management of renal colic, focusing on treatment decisions, time to treatment and the subsequent nee...
Lilli Winck-Flyvholm,Mikkel Fode,Anne Marsh et al. Lilli Winck-Flyvholm et al.
Objective: Transurethral microwave thermotherapy (TUMT) is well described for lower urinary tract symptoms in men with prostates between 30 and 100 grams. We aimed to describe the results in men with prostates larger than...
Torben Brøchner Pedersen,Mads Hvid Poulsen,Martin Lund et al. Torben Brøchner Pedersen et al.
Objective: Early and accurate diagnosis of prostate cancer (PC) is crucial for effective treatment. Diagnosing clinically insignificant cancers can lead to overdiagnosis and overtreatment, highlighting the importance of a...
Emir Majbar,Jakob Swanberg,Farhood Alamdari et al. Emir Majbar et al.
Objective: The aim of this study was to evaluate the early experiences of prostate artery embolization (PAE) in patients with benign prostatic hyperplasia (BPH). ...
Jovana Maljkovic,Anna Bill-Axelson,Hampus Hållberg et al. Jovana Maljkovic et al.
Objective: Active surveillance (AS) is recommended for low-risk and some favourable intermediate-risk prostate cancers, but criteria for AS and deferred treatment have changed over time. We assessed time trends for the us...